EGFR and nasopharyngeal carcinoma: Meanwhile, shorter-use cycles of CTX and NTZ (meaning lower cost) in this treatment, compared to EGFR-targeted agents combined with concurrent chemoradiotherapy (CCRT), are instructive for the treatment of LA-NPC [97].